Business profile

Friberg Medicine Oy

Friberg Medicine Oy's registered office is Julkujärvi. It is a limited company. The company was established on 2024-02-08. It operates in the industry of medical specialists activities. In its latest retained statement for 2025-12-31, revenue was €274,510 and operating profit was €23,673.

Claim profileContact details
Business ID 3422816-9ValidUnclaimed company profile

Trusted core data

Public company details from the trade register.

Business ID
3422816-9
Sector
Medical specialists activities
Municipality
Julkujärvi
Company form
Limited company
Registration date
2024-02-08
Business ID registration date
2024-01-27
Business status
Valid
Profile ownership
Unclaimed company profile

Contact and location summary

Visiting address: Tiirantie 3, 39160, Julkujärvi

About Friberg Medicine Oy

Financial position and key figures for the company.

Friberg Medicine Oy's location municipality is Julkujärvi. It is a limited company. The company was established on 2024-02-08. It operates in the industry of medical specialists activities. In its latest retained statement for 2025-12-31, revenue was €274,510 and operating profit was €23,673. The latest retained financial statement for 2025-12-31 shows revenue of €274,510 and profit for the financial year of €15,608. Based on the latest retained statement, revenue growth was +153.7%, operating margin was +8.6%, and equity ratio was +28.8%.

Financial highlights

Key figures from the latest financial period.

Open full statement
Latest financial period

2025-12-31

Imported periods2
PRH parsed2
Profile sourcePRH/XBRL financial statement
Derived indicators
Revenue growth153.7%
Operating margin8.6%
Equity ratio28.8%
Revenue€274,510+€166,303 (+153.7%) vs previous periodPrevious: €108,207
Operating profit (loss)€23,673-€12,440 (-34.4%) vs previous periodPrevious: €36,113
Profit (loss) for the financial year€15,608-€13,269 (-46.0%) vs previous periodPrevious: €28,878
Assets€146,560+€102,565 (+233.1%) vs previous periodPrevious: €43,996
Balance-sheet contextLatest financial period
Cash and bank€33,984Previous: €7,942
Retained earnings€26,568Previous: €0
Equity€42,176Previous: €28,878
Liabilities€104,385Previous: €15,118
Current assets€55,079Previous: €43,496
Current liabilities€14,883Previous: €15,118
Revenue trend2 periods
€108,207
2024-12-31
€274,510
2025-12-31
Operating profit (loss) trend2 periods
€36,113
2024-12-31
€23,673
2025-12-31
Profit (loss) for the financial year trend2 periods
€28,878
2024-12-31
€15,608
2025-12-31
Assets trend2 periods
€43,996
2024-12-31
€146,560
2025-12-31

Financial ratios

Financial ratios based on financial statement data. Source: PRH/XBRL-tilinpäätös.

Equity ratioPassable
36/100 · Declining
28.8 %2024-12-31: 65.6 %
Current ratioGood
76/100 · Improving
2.28x2024-12-31: 0.53x
Operating profit marginSatisfactory
72/100 · Declining
8.6 %2024-12-31: 33.4 %
Ratio history
Ratio2024-12-312025-12-31
Equity ratio65.6 %28.8 %
Current ratio0.53x2.28x
Operating profit margin33.4 %8.6 %

Registry status and identifiers

Current registry information and identifiers based on YTJ data.

YTJ statusValid
Trade RegisterRegistered
Business ID3422816-9
EU IDFIFPRO.3422816-9
MunicipalityJulkujärvi
Current registered entries
2024-01-27Registered in Tax Administration (Prepayment Register)
2024-02-08Registered in Tax Administration (Tax Administration)
2024-02-08Registered in Patent and Registration Office (Trade Register)

Risk certificate

An open-data based company stability and risk signal.

BUSINESS.fi

BUSINESS.fi Luottoluokitus

Profile-specific risk signal based on open data

Automatic gradeNot a credit decision
A3
GoodFriberg Medicine Oy
Grade unchangedA3 · new analysis 2026-10-17
Model score71/100
Assessment confidenceHigh
Evidence qualityStrong financial evidenceFinancial data included
Financial trajectorySeveral key financial indicators have weakened across comparable fiscal periods.
2 comparable periods
RevenueImproving
ProfitabilityDeteriorating
SolvencyDeteriorating
LiquidityImproving
Peer comparisonSame industry and sizeDescriptive comparison – does not change the model score.
93 peers
Solvency8%
Below 92% of peers
Profitability26%
Below 74% of peers
Liquidity50%
Close to the peer-group midpoint
Revenue growth97%
Better than 97% of peers
Financial statement reporting patternRegularBased on observed PRH financial period end and registration dates. This descriptive evidence does not change the v0.14 score.
2 observed filings
Latest registration lag108 days after period end
Typical registration lag119 days after period end
Annual continuity2 consecutive periods
Supporting factors
  • Strong operating profitability
  • Healthy short-term liquidity
  • Active registered status
Risk factors to note
  • Coordinated deterioration across 2 financial domains
Rating historyAutomatic assessment developmentChanges are derived from evidence differences between persisted automatic assessments.
5 assessments
A3
2026-10-1771/100 · v0.15
A3 → A3
A3
2026-09-17 06:2471/100 · v0.14
B2 → A3 · +14 points
  • Evidence strengthened: a PRH/XBRL financial statement was added to the assessment (2025-12-31).
  • Assessment confidence: Medium → High.
  • Evidence quality: Registry and statistical evidence → Strong financial evidence.
B2
2026-09-1457/100 · v0.14
B2 → B2
B2
2026-09-1457/100 · v0.13
Oldest retained automatic assessment in this comparison
Automatic model gradeA3
Automatic model snapshot2026-10-17
Automatic model versionopen-risk-grade-v0.15
Financial data included

The grade can use open digital financial statement data together with registry signals.

Verify assessment

Risk context

When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.

Industry riskvery low
94/100

Industry context is very low based on normalized open statistical inputs.

Age and continuityNuori
15/100

The company has about 2 years of registry continuity.

Registry and status signalsRajallinen
39/100

Registry history, filing recency, and active register markings are still limited or mixed.

Events & news

Verified events and sourced external company news in one timeline.

Risk grade updatedRisk gradeEvidence verified
17 Oct 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade A3.
Risk grade updatedRisk gradeEvidence verified
17 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B2 → A3.
Risk grade updatedRisk gradeEvidence verified
14 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B2.

Registry timeline

Trade register notifications shown on a timeline.

4 register eventsLatest event: 2026-04-18

Financial statements availability

Available financial statement periods and PRH source filings.

2 financial statement periodsLatest financial period: 2025-12-31

Profile source and ownership

Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.

This company profile has not been claimed yet

Friberg Medicine Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.